Invitae Corporation
NYSE:NVTA
0.019 (USD) • At close February 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 516.303 | 460.449 | 279.598 | 216.824 | 147.699 | 68.221 | 25.048 | 8.378 | 1.604 | 0.148 | 0 |
Cost of Revenue
| 417.256 | 348.669 | 198.275 | 118.103 | 80.105 | 50.142 | 27.878 | 16.523 | 5.624 | 0.667 | 0 |
Gross Profit
| 99.047 | 111.78 | 81.323 | 98.721 | 67.594 | 18.079 | -2.83 | -8.145 | -4.02 | -0.519 | 0 |
Gross Profit Ratio
| 0.192 | 0.243 | 0.291 | 0.455 | 0.458 | 0.265 | -0.113 | -0.972 | -2.506 | -3.507 | 0 |
Reseach & Development Expenses
| 402.088 | 416.087 | 240.605 | 141.526 | 63.496 | 46.469 | 44.63 | 42.806 | 22.14 | 16.039 | 5.557 |
General & Administrative Expenses
| 192.314 | 248.07 | 324.573 | 79.07 | 52.227 | 39.472 | 24.085 | 16.047 | 12.605 | 5.764 | 3.004 |
Selling & Marketing Expenses
| 218.881 | 225.91 | 168.317 | 122.237 | 74.428 | 53.417 | 28.638 | 22.479 | 8.763 | 2.431 | 0 |
SG&A
| 411.195 | 473.98 | 492.89 | 201.307 | 126.655 | 92.889 | 52.723 | 38.526 | 21.368 | 8.195 | 3.004 |
Other Expenses
| 8.054 | 25.678 | -32.332 | -3.891 | -2.568 | -0.303 | 0.348 | -0.094 | -0.079 | -0.026 | 0.002 |
Operating Expenses
| 813.283 | 890.067 | 733.495 | 342.833 | 190.151 | 139.358 | 97.353 | 81.332 | 43.508 | 24.234 | 8.561 |
Operating Income
| -714.236 | -778.287 | -652.172 | -244.112 | -122.557 | -121.279 | -100.183 | -89.477 | -47.528 | -24.753 | -8.561 |
Operating Income Ratio
| -1.383 | -1.69 | -2.333 | -1.126 | -0.83 | -1.778 | -4 | -10.68 | -29.631 | -167.25 | 0 |
Total Other Income Expenses Net
| -2,436.961 | 362.424 | -62.098 | -16.303 | -9.598 | -3.957 | -0.073 | -0.305 | 0.036 | -0.085 | -0.041 |
Income Before Tax
| -3,151.197 | -415.863 | -714.27 | -260.415 | -132.155 | -125.236 | -100.256 | -89.782 | -47.668 | -24.838 | -8.602 |
Income Before Tax Ratio
| -6.103 | -0.903 | -2.555 | -1.201 | -0.895 | -1.836 | -4.003 | -10.716 | -29.718 | -167.824 | 0 |
Income Tax Expense
| -44.904 | -36.857 | -105.4 | -18.45 | -2.8 | -1.856 | -5.784 | -5.11 | -2.333 | 0.033 | 0.045 |
Net Income
| -3,106.293 | -379.006 | -608.87 | -241.965 | -129.355 | -123.38 | -100.256 | -89.782 | -47.668 | -24.838 | -8.602 |
Net Income Ratio
| -6.016 | -0.823 | -2.178 | -1.116 | -0.876 | -1.809 | -4.003 | -10.716 | -29.718 | -167.824 | 0 |
EPS
| -13.18 | -1.8 | -4.52 | -2.66 | -1.94 | -2.65 | -3.02 | -3.18 | -1.6 | -1.67 | -0.58 |
EPS Diluted
| -13.18 | -1.8 | -4.52 | -2.66 | -1.94 | -2.65 | -3.02 | -3.18 | -1.6 | -1.67 | -0.58 |
EBITDA
| -3,118.41 | -391.641 | -652.172 | -244.112 | -111.585 | -121.582 | -93.63 | -89.477 | -45.189 | -23.851 | -8.282 |
EBITDA Ratio
| -1.093 | -1.46 | -2.309 | -1.069 | -0.755 | -1.782 | -3.986 | -10.68 | -29.68 | -161.155 | 0 |